- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04471103
Comparison of Multi-Round and Real-Time Delphi Survey Methods
Multi-round Compared to Real-Time Delphi for Consensus in Core Outcome Set (COS) Development: A Randomised Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim:
The aim of this trial is to compare a multi-round Delphi survey method with a Real-Time Delphi method on prioritised outcomes included in a core outcome set (COS). This trial is embedded within the COHESION study which is developing a COS for interventions for the treatment of neonatal encephalopathy.
Methods:
Stakeholders (parents/ caregivers of infants diagnosed and treated with neonatal encephalopathy, healthcare providers and researchers) will be randomised using stratified randomisation to take part in either a multi-round or Real-Time Delphi. Stakeholders will rate the importance of the same set of outcomes in both arms. We will compare the prioritised outcomes at the end of both surveys as well as other parameters such as feedback, initial condition and iteration effects.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fiona A Quirke, BSc
- Phone Number: +353 91 495 481
- Email: f.quirke1@nuigalway.ie
Study Locations
-
-
-
Galway, Ireland, H91 W6P8
- Recruiting
- HRB-TMRN
-
Contact:
- Declan M Devane, PhD
- Phone Number: 091 49 5828
- Email: declan.devane@nuigalway.ie
-
Contact:
- Sandra Galvin, PhD
- Phone Number: 091 494493
- Email: sandra.galvin@nuigalway.ie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- parents or caregivers of infants that have been diagnosed with and received treatment for neonatal encephalopathy
healthcare providers including:
- neonatal nurse practitioners
- midwives
- obstetricians
- neonatologists/paediatricians
- neonatal/paediatric neurologists
- general practitioners who provide long-term care for children with neonatal encephalopathy
- policymakers
- researchers/ academics with expertise in neonatal encephalopathy treatment.
Exclusion Criteria:
• participants not meeting the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real-Time Delphi Method
The Real-Time Delphi Method involves a single-round Delphi survey rating the importance of outcomes for neonatal encephalopathy.
Feedback on each outcome (participant's own rating score, rating of the outcome by stakeholder group and overall consensus results for that outcome) will be provided to the participant once they have rated an outcome.
They can then modify how they rated the outcome based on this feedback if they wish.
Participants can also re-visit and re-rate outcomes as many times as they wish when the survey is live.
Duration will span approximately 5 weeks.
|
Participants will be asked to participate in an online Delphi survey (using one of two randomly allocated methods) to rate the importance of outcomes that should be measured to determine the effect of treatment for neonatal encephalopathy.
Outcomes will be prioritised on their importance in a consensus-driven manner.
|
|
Active Comparator: Multi-round Delphi Method
The Multi-Round Delphi Method involves a three-round Delphi survey rating the importance of outcomes for neonatal encephalopathy.
Feedback on each outcome (participant's own rating score, rating of the outcome by stakeholder group and overall consensus results for that outcome) will be provided to the participant at the end of Round 1 and the end of Round 2. Participants can then modify how they rated the outcome based on feedback, in Rounds 2 and 3, if they wish.
Each survey Round will run for 3 weeks approximately.
In between survey Rounds, there will be a downtime of approximately 10 days before providing feedback and a further 7 days before starting the next round.
Duration will span approximately 14 weeks.
|
Participants will be asked to participate in an online Delphi survey (using one of two randomly allocated methods) to rate the importance of outcomes that should be measured to determine the effect of treatment for neonatal encephalopathy.
Outcomes will be prioritised on their importance in a consensus-driven manner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of outcomes prioritised within each survey arm
Time Frame: End of both surveys (i.e. when the Multi-Round Delphi round 3 has finished and when the Real-Time Delphi has finished at the end of week 5).
|
Comparison of outcomes prioritised by respondents at the end of (i) the Real-time and (ii) multi-round Delphi processes.
An outcome is judged 'prioritised' based on the proportion of respondents rating the outcome a 7-9 (inclusive) on a 9-point Likert scale (higher scores = higher importance for inclusion in the COS)
|
End of both surveys (i.e. when the Multi-Round Delphi round 3 has finished and when the Real-Time Delphi has finished at the end of week 5).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feedback Effect
Time Frame: Through study completion, an average of 14 weeks.
|
The feedback effect will tell if the feedback provided to participants resulted in them amending the rating they have to each outcome on the 9-point scale (higher scores= higher importance for inclusion in the COS)
|
Through study completion, an average of 14 weeks.
|
|
Initial Condition Effect
Time Frame: During the Real-Time Delphi intervention (5 weeks).
|
The initial condition effect will capture if early participant's rating for each outcome on the 9-point scale ( higher scores= higher importance for inclusion in the COS) differs to rating given by later participants.
|
During the Real-Time Delphi intervention (5 weeks).
|
|
Iteration Effect
Time Frame: Through study completion, an average of 14 weeks.
|
The iteration effect will determine if there is a difference in how consensus is achieved on prioritising each outcome or not, between the Multi-Round and the Real-Time Delphi survey arms
|
Through study completion, an average of 14 weeks.
|
|
Comparison of outcomes prioritised within each survey arm with the final Core Outcome Set
Time Frame: Through study completion, an average of 1 year.
|
Comparison of the of outcome headings prioritised at the end of both the Real-Time and Multi-Round Delphi processes with the outcome headings in the final Core Outcome Set.
|
Through study completion, an average of 1 year.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attrition rates
Time Frame: Attrition rates will be recorded at the end of round 1 (week 3) and round 2 (week 9) in the Multi-Round Delphi and at weeks 2 and 4 in the Real-Time Delphi arm.
|
Comparison of attrition rates between multi-round and Real-Time Delphi arms.
|
Attrition rates will be recorded at the end of round 1 (week 3) and round 2 (week 9) in the Multi-Round Delphi and at weeks 2 and 4 in the Real-Time Delphi arm.
|
|
Frequency of re-visiting the Real-Time Delphi arm
Time Frame: This will be measured when a participant visits the Real-Time Delphi survey and rates the outcomes fully for a second time (between the start of week 1 and the end of week 5).
|
Monitoring how often the Real-Time Delphi was re-visited by participants
|
This will be measured when a participant visits the Real-Time Delphi survey and rates the outcomes fully for a second time (between the start of week 1 and the end of week 5).
|
|
Usefulness, Satisfaction and Ease of Use of each survey arm
Time Frame: End of both surveys (i.e. when the Multi-Round Delphi round 3 (week 14) has finished and when the Real-Time Delphi has finished at the end of week 5)
|
Participants will be asked in a short questionnaire how they found answering each survey using a modified Usefulness, Satisfaction and Ease of use questionnaire on a 7-point Likert Scale where 1= Strongly Disagree and 7=Strongly Agree.
|
End of both surveys (i.e. when the Multi-Round Delphi round 3 (week 14) has finished and when the Real-Time Delphi has finished at the end of week 5)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Declan Devane, PhD, Health Research Board - Trials Methodology Research Network
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NUIreland-COHESION
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Consensus Development
-
University of Southern CaliforniaCompleted
-
University of Southern CaliforniaEnrolling by invitationConsensus DevelopmentUnited States
-
Ohio State UniversityRecruitingConsensus DevelopmentUnited States
-
Istanbul Bilgi UniversityCompleted
-
Charite University, Berlin, GermanyCompleted
-
The University of Hong KongGerontechnology Platform, The Social Innovation and Entrepreneurship Development...CompletedConsensus DevelopmentHong Kong
-
University of Southern CaliforniaEnrolling by invitationConsensus DevelopmentUnited States
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation Trust; South Yorkshire and Bassetlaw...UnknownNurse's Role | ACP | Development, ConsensusUnited Kingdom
-
University of British ColumbiaCompleted
-
ThinkWellCompletedDecisional Variability by Presentation Methods for ConsensusUnited Kingdom
Clinical Trials on Participation in a Delphi survey
-
Global Foundation for the Care of Newborn InfantsNot yet recruitingStress, Psychological | Anxiety | Caregiver Burden | Parents | Emotions | Fear | Uncertainty | Infant, Premature | Infant, Low Birth Weight | Life Change Events | Needs AssessmentGermany
-
IRCCS Policlinico S. DonatoWithdrawnAdults Undergoing Oral Anticoagulation TherapyItaly
-
University Hospital, CaenINSERM UMR U1075 Comète GIP Cyceron, unicaen, Caen NormandieNot yet recruitingDeveloping a Consensus Framework to Standardize Isokinetic Testing Data Reporting
-
Frederiksberg University HospitalCompletedMusculoskeletal Diseases | Osteoarthritis, Knee | Illness PerceptionsDenmark
-
University of NottinghamKing's College London; National Institute for Health Research, United KingdomRecruitingFibrosis | Arthroplasty Complications | Knee Joint ContractureUnited Kingdom
-
Utica CollegeCompleted
-
Chinese University of Hong KongMemorial Sloan Kettering Cancer Center; Chinese Medicine Development Fund; Chinese... and other collaboratorsRecruitingHerb-drug InteractionsHong Kong
-
Centre Hospitalier Intercommunal CreteilCompleted
-
University of NottinghamNottingham University Hospitals NHS Trust; The Dunhill Medical TrustActive, not recruitingFalls | Vision; Disorder, LossUnited Kingdom
-
Leiden University Medical CenterRecruiting